We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPABW
12076
DELISTED
New Providence Acquisition Corp. II Warrant
NPABW
$33K ﹤0.01%
276,086
-57,246
-17% -$14.9K
BBDO icon
12077
Banco Bradesco
BBDO
$32.9B
$32K ﹤0.01%
+11,861
New +$37.9K
BJDX icon
12078
Bluejay Diagnostics
BJDX
$1.09M
$32K ﹤0.01%
+1
New +$35.5K
BNED icon
12079
CALL
Barnes & Noble Education
BNED
$421M
$32K ﹤0.01%
109
-47
-30% -$13.6K
CRDL
12080
Cardiol Therapeutics
CRDL
$207M
$32K ﹤0.01%
23,891
-4,561
-16% -$6.49K
EMX
12081
DELISTED
EMX Royalty
EMX
$32K ﹤0.01%
17,389
-4,034
-19% -$8.09K
EQ icon
12082
CALL
Equillium
EQ
$150M
$32K ﹤0.01%
+15,700
New +$39.4K
LITS
12083
CALL
Lite Strategy Inc
LITS
$30.2M
$32K ﹤0.01%
2,635
-1,020
-28% -$11.1K
WATT icon
12084
PUT
Energous
WATT
$86M
$32K ﹤0.01%
54
-13
-19% -$7.92K
LENZ
12085
PUT
LENZ Therapeutics
LENZ
$149M
$32K ﹤0.01%
+1,671
New +$37.3K
IRD
12086
Opus Genetics
IRD
$300M
$32K ﹤0.01%
+16,458
New +$37.4K
CBAY
12087
PUT
DELISTED
Cymabay Therapeutics
CBAY
$32K ﹤0.01%
10,800
-600
-5% -$1.43K
MTCR
12088
CALL
DELISTED
Metacrine, Inc. Common Stock
MTCR
$32K ﹤0.01%
64,300
-900
-1% -$436
EQOS
12089
CALL
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$32K ﹤0.01%
38,600
+1,700
+5% +$2.27K
EPZM
12090
CALL
DELISTED
Epizyme, Inc
EPZM
$32K ﹤0.01%
21,600
-4,500
-17% -$3.31K
WMC
12091
CALL
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$32K ﹤0.01%
2,660
+1,010
+61% +$13.7K
ADVM
12092
DELISTED
Adverum Biotechnologies
ADVM
$31K ﹤0.01%
2,528
-5,179
-67% -$54.3K
BNBX
12093
DELISTED
BNB PLUS CORP
BNBX
$31K ﹤0.01%
+3
New +$63.5K
DTSS icon
12094
Datasea Intelligent Technology Ltd
DTSS
$7.98M
$31K ﹤0.01%
+1,278
New +$42.4K
EBON icon
12095
PUT
Ebang International Holdings
EBON
$12.7M
$31K ﹤0.01%
2,547
-520
-17% -$12.7K
HRTX icon
12096
CALL
Heron Therapeutics
HRTX
$63.9M
$31K ﹤0.01%
11,200
-16,600
-60% -$66.7K
JSPR icon
12097
CALL
Jasper Therapeutics
JSPR
$26.3M
$31K ﹤0.01%
1,610
-550
-25% -$15.7K
LAB icon
12098
CALL
Standard BioTools
LAB
$280M
$31K ﹤0.01%
19,600
+3,000
+18% +$7.42K
NEWP
12099
CALL
New Pacific Metals
NEWP
$1.27B
$31K ﹤0.01%
+10,800
New +$34.4K
PXLW icon
12100
PUT
Pixelworks
PXLW
$42.2M
$31K ﹤0.01%
1,333
-2,550
-66% -$66K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.